Emulate Blog

Cell Central

A blog dedicated to next generation in vitro models

October 7, 2021 | Emulate Endorsement

Emulate Endorses the FDA Modernization Act of 2021

In April 2021, a bipartisan congressional committee took a big step towards modernizing the way therapeutics are developed in the United States by proposing the FDA Modernization Act of 2021…

October 8, 2021 | Customer Spotlight

Customer Spotlight: Queen Mary University London’s Centre for Predictive in vitro Models

At Queen Mary University London (QMUL), scientists across many disciplines are using in vitro models to explore the fundamental biology of health and disease and to develop…

August 22, 2021 | Cancer

Using Organs-On-Chips to Evaluate On-Target/Off-Tumor Effects of Cancer Immunotherapies

Cancer immunotherapy approaches are having their moment in the clinical spotlight. Over two decades of work characterizing potent activators of the immune…

Image for Emulate Endorses the FDA Modernization Act of 2021

Emulate Endorses the FDA Modernization Act of 2021

Read More
Image for Charting Our Path Forward: Determination and Resilience Attracts $82M Series E Funding

Charting Our Path Forward: Determination and Resilience Attracts $82M Series E Funding

Read More
Image for Customer Spotlight: Queen Mary University London’s Centre for Predictive in vitro Models

Customer Spotlight: Queen Mary University London’s Centre for Predictive in vitro Models

Read More
Image for Creating an Effective Pre-Clinical Model of Bone Marrow

Creating an Effective Pre-Clinical Model of Bone Marrow

Read More
Image for Modeling a Better Human Immune Response to Vaccination Using Lymphoid Follicle Organ-Chips

Modeling a Better Human Immune Response to Vaccination Using Lymphoid Follicle Organ-Chips

Read More
Image for Using Organs-On-Chips to Evaluate On-Target/Off-Tumor Effects of Cancer Immunotherapies

Using Organs-On-Chips to Evaluate On-Target/Off-Tumor Effects of Cancer Immunotherapies

Read More